Cinda HK $1.2 billion guaranteed and floating-rate notes offerings
We advised the joint lead managers on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Shenzhen Xunce Technology HK$1.08 billion IPO
We advised Xunce on its IPO and HKEX listing
PegBio HK$300 million placement of shares
We advised PegBio on the placement of new shares
HashKey Holdings HK$1.6 billion IPO
We advised HashKey on its IPO and HKEX listing
Pony AI HK$6.71 billion dual primary listing on the Hong Kong Stock Exchange
We advised Pony AI on its dual primary listing on HKEX
Biocytogen RMB1.27 billion Shanghai IPO
We advised Biocytogen on its IPO and SSE listing
Seyond Holdings HK$11.7 billion de-SPAC transaction and private placement
We advised Seyond on the transactions
Meituan multiple-tranche, dual-currency senior notes offerings
We advised Meituan on the transaction
DFZQ $300 million floating-rate bonds offering
The investment-grade bonds are due 2028